I am an analyst and Level II Candidate in the CFA Program that has gained experience in the investment industry through positions as a proprietary trader and a portfolio management administrator. I look for a way to minimize risk in biopharmaceutical investing through conservative pipeline valuation and balance sheet analysis to identify companies with a compelling upside potential and risk profile. Along with my stock-specific analysis pieces, I write a column called Biotech Weekly where I discuss a major theme in the industry. I also am very interested in applying knowledge of the markets in a way to improve personal finance. My articles have appeared on the websites of CNBC, Seeking Alpha, Reuters, Google Finance, Morningstar, NASDAQ, MarketWatch, and the International Business Times.
You did not called any pullbacks
You said that there will be an offering,trying to create fear on newbies so you can pick up cheap shares.
You are worst than the fawking bashers
IGGY time for you